Skip to content. Skip to navigation
Personal tools
  Members Area  

ANZCA

Sections
You are here: Home ANZCA
Navigation
News
24-08-2008
New drug
A new drug has just been approved for use in Australia. SITAGLIPTIN (Januvia) is an oral drug for type 2 Diabetes mellitus. It is a new class of drug, a dipeptidyl peptidase (DPP-4) inhibitor. Sitagliptin is an 'incretin enhancer' that increases the levels of active incretin by inhibiting their metabolism by DPP-4, thus prolonging their effect in stimulating insulin release and decreasing glucagon secretion.
24-08-2008
The latest ANZCA e-newsletter has been emailed
The latest edition of ANZCA’s e-newsletter has now been emailed to Fellows, trainees and ANZCA staff.
21-08-2008
Fellowship Affairs
The first meeting of the Fellowship Affairs Committee was held on Friday, 15 August 2008. Chaired by Dr Margaret Cowling, the Committee oversees all matters directly pertinent to Fellows, including CPD, annual scientific meetings, Regional CME and SIG events, communications and professional issues
20-08-2008
RFT for Australian Clinical Quality Registries pilot projects
The Australian Commission on Safety and Quality in Health Care is seeking tenders from relevant organisations to test and validate the draft 'Operating Principles and Technical Standards for Australian Clinical Quality Registries'.
20-08-2008
Electricity & greenhouse emissions
You might wonder whether turning off the lights when not required actually saves energy. Thanks to the efforts of College staff, we have saved a massive 15 per cent greenhouse gas emissions over the last six months compared to last year. A lot of this can be attributed to turning off lights and switching to energy efficient flourescent light globes. The impact has been significant.
More news…
 
Document Actions

ANZCA

The Australian and New Zealand College of Anaesthetists (ANCollege HeadquartersZCA) was incorporated in February 1992. For the forty years prior to that, the functions of the College had been carried out by the Faculty of Anaesthetists, Royal Australasian College of Surgeons (RACS) which was formed in 1952.

The Mission Statement of the College is "To Serve the Community by Fostering Safety and Quality Patient Care in Anaesthesia, Intensive Care and Pain Medicine".

From the Mission Statement flows three major objectives of the Mission Statement :

  1. To promote professional standards and patient safety in anaesthesia, intensive care and pain management. 
  2. To promote education in anaesthesia, intensive care and pain management.
  3. To advance the science and practice of anaesthesia, intensive care and pain management.

 

The College's function is thus to cultivate and maintain the highest principles and standards in the training, practice and ethics of anaesthesia, intensive care and pain medicine.  To assist Council in achieving its objectives, the College engages professional and administrative staff located at ANZCA House, in the New Zealand National Office, and in state and territory Regional Offices.

The Joint Faculty of Intensive Care Medicine (JFICM) and the Faculty of Pain Medicine (FPM), through their independent Boards, assist Council in achieving these objectives in the areas of intensive care medicine and pain medicine respectively.

 At the end of 2006, there were 4,091 active and retired fellows of the College.  Thirty three per cent (33%) of these Fellows were female, 67 per cent were male.  There were 1,345 Trainees spread across the five training years, together with 371 Trainees who had registered with the College but were not currently actively engaged in training.

Further Information